(-0.13%) 5 140.25 points
(-0.11%) 38 517 points
(-0.07%) 17 891 points
(-0.31%) $82.37
(1.63%) $2.06
(-0.98%) $2 334.60
(-2.11%) $27.08
(-0.61%) $955.60
(0.25%) $0.935
(0.51%) $11.04
(0.23%) $0.798
(-0.31%) $93.01
-0.54% $ 0.0551
Live Chart Being Loaded With Signals
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States...
Stats | |
---|---|
Dagens volum | 8 136.00 |
Gjennomsnittsvolum | 41 765.00 |
Markedsverdi | 674 016 |
EPS | $0 ( 2024-03-29 ) |
Neste inntjeningsdato | ( $0 ) 2024-06-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0600 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-13 | Puissance Capital Management Lp | Sell | 1 076 841 | Common Stock |
2023-06-07 | Amin Naseem | Buy | 47 578 | Common Stock |
2023-06-07 | Fernandes Peter | Sell | 100 000 | Stock Options (Right to Buy) |
2023-06-07 | Shah Parag Suresh | Sell | 50 000 | Stock Options (Right to Buy) |
2023-06-07 | Dekker Martin | Sell | 50 000 | Stock Options (Right to Buy) |
INSIDER POWER |
---|
-74.15 |
Last 99 transactions |
Buy: 6 532 145 | Sell: 5 633 542 |
Bellerophon Therapeutics Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
CPTA | 0.936 |
SGEN | 0.934 |
RETA | 0.929 |
ORTX | 0.928 |
NVCT | 0.924 |
XLRN | 0.922 |
DUOL | 0.92 |
FLMN | 0.919 |
LMB | 0.919 |
RELY | 0.918 |
10 Mest negative korrelasjoner | |
---|---|
CMLS | -0.959 |
JRJC | -0.949 |
AADI | -0.947 |
CPTN | -0.944 |
MICS | -0.942 |
IHRT | -0.942 |
MDRX | -0.942 |
EYE | -0.941 |
ESSA | -0.94 |
SILK | -0.938 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Bellerophon Therapeutics Økonomi
Annual | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-2.08 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $0 (0.00 %) |
EPS: | $-2.08 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.870 |
FY | 2020 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-3.17 |
Financial Reports:
No articles found.
Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.